Abstract
Periprosthetic joint infection (PJI) is a serious complication that may occur after native joint replacement leading to a severe health and economic burden. Currently, due to several confounding factors, PJI is difficult to diagnose. Today, a multidisciplinary approach is indispensable to correctly define a periprosthetic joint infection; indeed, tissue histology, microbiology cultures and clinical findings are used together to achieve this goal. Analysis of α-defensin is commonly used for PJI diagnosis, as it allows the rapid detection of α-defensin present in the synovial fluid following a microbial infection. Currently, a point-of-care testing (POCT) assay able to detect the presence of human α-defensins 1–3 in synovial fluid of patients is aimed directly at orthopedic surgeons. However, many orthopedic surgeons lack experience and training in quality laboratory practices, often failing to appreciate the significance of quality control and proper documentation when using POCT assays. To guarantee the highest quality diagnostic services, the α-defensin test should be used together with other biochemical and microbiological criteria commonly used for PJI diagnosis. Additionally, the close cooperation and communication between laboratory, pathologists and physicians is of fundamental importance in the correct diagnosis of PJI.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Booth RE Jr, et al. The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res 2015;473:198–203.10.1007/s11999-014-3722-7Search in Google Scholar PubMed PubMed Central
2. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012;27:61–5.10.1016/j.arth.2012.02.022Search in Google Scholar PubMed
3. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014;27:302–45.10.1128/CMR.00111-13Search in Google Scholar PubMed PubMed Central
4. Hozack WJ, Parvizi J. New definition for periprosthetic joint infection. J Arthroplasty 2011;26:1135.10.1016/j.arth.2011.09.025Search in Google Scholar PubMed
5. De Vecchi E, Bottagisio M, Bortolin M, Toscano M, Lovati AB, Drago L. Improving the bacterial recovery by using dithiothreitol with aerobic and anaerobic broth in biofilm-related prosthetic and joint infections. Adv Exp Med Biol 2016.10.1007/5584_2016_51Search in Google Scholar PubMed
6. De Vecchi E, Bortolin M, Signori V, Romanò CL, Drago L. Treatment With dithiothreitol improves bacterial recovery from tissue samples in osteoarticular and joint infections. J Arthroplasty 2016;31:2867–70.10.1016/j.arth.2016.05.008Search in Google Scholar PubMed
7. Drago L, Signori V, De Vecchi E, Vassena C, Palazzi E, Cappelletti L, et al. Use of dithiothreitol to improve the diagnosis of prosthetic joint infections. J Ortho Res 2013;31:1694–9.10.1002/jor.22423Search in Google Scholar PubMed
8. Drago L, Romanò CL, Mattina R, Signori V, De Vecchi E. Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study. Clin Orthop Relat Res 2012;470:2915–25.10.1007/s11999-012-2415-3Search in Google Scholar PubMed PubMed Central
9. De Vecchi E, Villa F, Bortolin M, Toscano M, Tacchini L, Romanò CL, et al. Leucocyte esterase, glucose and C-reactive protein in the diagnosis of prosthetic joint infections: a prospective study. Clin Microbiol Infect 2016;22:555–60.10.1016/j.cmi.2016.03.020Search in Google Scholar PubMed
10. Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hapfelmeier A, et al. Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am 2013;95:644–51.10.2106/JBJS.L.00205Search in Google Scholar PubMed
11. Jacovides CL, Parvizi J, Adeli B, Jung KA. Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplasty 2011;26:99–103.10.1016/j.arth.2011.03.025Search in Google Scholar
12. Lehrer RI, Ganz T. Defensins: endogenous antibiotic peptides from human leukocytes. Ciba Found Symp 1992;171:276–93.10.1002/9780470514344.ch16Search in Google Scholar
13. Selsted ME, White SH, Wimley WC. Structure, function, and membrane integration of defensins. Curr Opin Struct Biol 1995;5:521–7.10.1016/0959-440X(95)80038-7Search in Google Scholar
14. Rodríguez-García M, Oliva H, Climent N, García F, Gatell JM, Gallart T. Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J Leukoc Biol 2007;82:1143–6.10.1189/jlb.0507295Search in Google Scholar PubMed
15. Shahi A, Parvizi J, Kazarian GS, Higuera C, Frangiamore S, Bingham J, et al. The alpha-defensin test for periprosthetic joint infections is not affected by prior antibiotic administration. Clin Orthop Relat Res 2016;47:1610–5.10.1007/s11999-016-4726-2Search in Google Scholar PubMed PubMed Central
16. Colvin OC, Kransdorf MJ, Roberts CC, Chivers FS, Lorans R, Beauchamp CP, et al. Leukocyte esterase analysis in the diagnosis of joint infection: can we make a diagnosis using a simple urine dipstick? Skeletal Radiol 2015;44:673–7.10.1007/s00256-015-2097-5Search in Google Scholar PubMed
17. Zmistowski B, Della Valle C, Bauer TW, Malizos KN, Alavi A, Bedair H, et al. Diagnosis of periprosthetic joint infection. J Arthroplasty. 2014;29:77–83.10.1016/j.arth.2013.09.040Search in Google Scholar PubMed
18. Bonanzinga T, Zahar A, Dütsch M, Lausmann C, Kendoff D, Gehrke T. How Reliable Is the Alpha-defensin Immunoassay Test for Diagnosing Periprosthetic Joint Infection? A Prospective Study. Clin Orthop Relat Res 2017;475:408–15.10.1007/s11999-016-4906-0Search in Google Scholar PubMed PubMed Central
19. Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C, Goldberg B. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res 2014;472:4006–9.10.1007/s11999-014-3900-7Search in Google Scholar PubMed PubMed Central
20. Junker R, Schlebusch H, Luppa PB. Point-of-care testing in hospitals and primary care. Dtsch Arztebl Int 2010;107:561–7.10.3238/arztebl.2010.0561Search in Google Scholar PubMed PubMed Central
21. Luppa PB, Schlebusch H, editors. POCT – Patientennahe Labordiagnostik. Heidelberg: Springer Medizin Verlag, 2008.10.1007/978-3-540-79152-2Search in Google Scholar
22. Briedigkeit L, Müller-Plathe O, Schlebusch H, Ziems J. Patientennahe Laboratoriumsdiagnostik (Point-of-care Testing): 1. Empfehlungen der Arbeitsgemeinschaft Medizinische Laboratoriumsdiagnostik (AML) zur Einführung und Qualitätssicherung von Verfahren der patientennahen Laboratoriumsdiagnostik (POCT). J Lab Med 1998;22:414–20.Search in Google Scholar
23. Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of-care testing: a European perspective. Ups J Med Sci 2015;120:1–10.10.3109/03009734.2015.1006347Search in Google Scholar PubMed PubMed Central
24. Meyer-Lüerßen D, Meyer-Lüerßen I. Rechtssicherheit von Point-of-Care-Tests. J Lab Med 2006;30:230–3.Search in Google Scholar
25. Gregory K, Tse JY, Wu R, Lewandrowski K. Implementation of an expanded point-of-care testing (POCT) site inspection checklist in a large academic medical center: implications for the management of a POCT program. Clin Chim Acta 2012;414:27–33.10.1016/j.cca.2012.07.015Search in Google Scholar PubMed
26. Lee-Lewandrowski E, Gregory K, Lewandrowski K. Point-of care testing in a large academic medical center: evolving test menu and clinical applications. Clin Chim Acta 2010;411:1799–805.10.1016/j.cca.2010.08.002Search in Google Scholar PubMed
27. Gregory K, Lewandrowski K. Management of a point of care testing program. Clin Lab Med 2009;29:433–48.10.1016/j.cll.2009.06.006Search in Google Scholar PubMed
28. Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics and program management. Arch Pathol Lab Med 2011;135:1405–14.10.5858/arpa.2011-0157-RASearch in Google Scholar PubMed
29. Pecoraro V, Germagnoli L, Banfi G. Point-of-care testing: where is the evidence? A systematic survey. Clin Chem Lab Med 2014;52:313–24.10.1515/cclm-2013-0386Search in Google Scholar PubMed
30. Kasparek MF, Kasparek M, Boettner F, Faschingbauer M, Hahne J, Dominkus M. Intraoperative diagnosis of periprosthetic joint infection using a novel alpha-defensin lateral flow assay. J Arthroplasty 2016;31:2871–4.10.1016/j.arth.2016.05.033Search in Google Scholar PubMed
31. Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C, Goldberg B. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res 2014;472:4006–9.10.1007/s11999-014-3900-7Search in Google Scholar PubMed PubMed Central
32. Frangiamore SJ, Saleh A, Grosso MJ, Kovac MF, Higuera CA, Iannotti JP, et al. Alpha-defensin as a predictor of periprosthetic shoulder infection. J Shoulder Elbow Surg 2015;24:1021–7.10.1016/j.jse.2014.12.021Search in Google Scholar PubMed
33. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Combined measurement of synovial fluid α-defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am 2014;96:1439–45.10.2106/JBJS.M.01316Search in Google Scholar PubMed
34. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 2014;472:3254–62.10.1007/s11999-014-3543-8Search in Google Scholar PubMed PubMed Central
35. Frangiamore SJ, Gajewski ND, Saleh A, Farias-Kovac M, Barsoum WK, Higuera CA. Alpha-defensin accuracy to diagnose periprosthetic joint infection-best available test? J Arthroplasty 2016;31:456–60.10.1016/j.arth.2015.09.035Search in Google Scholar PubMed
36. Deirmengian C, Kardos K, Kilmartin P, Gulati S, Citrano P, Booth RE Jr. The alpha-defensin test for periprosthetic joint infection responds to a wide spectrum of organisms. Clin Orthop Relat Res 2015;473:2229–35.10.1007/s11999-015-4152-xSearch in Google Scholar PubMed PubMed Central
37. Frangiamore SJ, Gajewski ND, Saleh A, Farias-Kovac M, Barsoum WK, HigueraCA. Alpha-defensin accuracy to diagnose periprosthetic joint infection-best available test? J Arthroplasty 2016;31:456–60.10.1016/j.arth.2015.09.035Search in Google Scholar
38. Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med 2011;135:1405–14.10.5858/arpa.2011-0157-RASearch in Google Scholar PubMed
39. Zmistowski B, Della Valle C, Bauer TW, Malizos KN, Alavi A, Bedair H, et al. Diagnosis of periprosthetic joint infection. J Orthop Res 2014;32:S98–107.10.1002/jor.22553Search in Google Scholar PubMed
40. Corvec S, Loiez C, Portillo ME, Rottman M, Trampuz A. Bone and joint infactions. In: Cornaglia G, Courcol R, Herrmann JL, Kahlmeter G, Peigue-Lafeuille H, Vila J, editors. European manual of clinical microbiology. Paris, France: SFM, 2012:227–34.Search in Google Scholar
41. Ettinger M, Calliess T, Kielstein JT, Sibai J, Brückner T, Lichtinghagen R, et al. Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection, and high-grade septic failure. Clin Infect Dis 201;61:332–41.10.1093/cid/civ286Search in Google Scholar PubMed
42. Cembrowski GS. Thoughts on quality-control systems: a laboratorian’s perspective. Clin Chem 1997;43:886–92.10.1093/clinchem/43.5.886Search in Google Scholar
43. Shaw JL. Practical challenges related to point of care testing. Pract Lab Med 2016;4:22–9.10.1016/j.plabm.2015.12.002Search in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston